Theravance Biopharma (TBPH) FCF Margin Growth (1y) (2014 - 2026)
Theravance Biopharma (TBPH) FCF Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 869.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 811.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 769.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 19,111.00 |
| 10 | Theravance Biopharma | 880.59 Mn | 492.93 Mn | - | -82,792.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -82,792.00 |
| Mar 31, 2026 | 13,434.00 |
| Dec 31, 2025 | -741.00 |
| Sep 30, 2025 | -166.00 |
| Jun 30, 2025 | 82,555.00 |
| Mar 31, 2025 | 28,737.00 |
| Dec 31, 2024 | 289.00 |
| Sep 30, 2024 | -1,492.00 |
| Jun 30, 2024 | 6,543.00 |
| Mar 31, 2024 | 10,905.00 |
| Dec 31, 2023 | -38,176.00 |
| Sep 30, 2023 | 11,640.00 |
| Jun 30, 2023 | 3,768.00 |
| Mar 31, 2023 | 8,272.00 |
| Dec 31, 2022 | 65,993.00 |
| Sep 30, 2022 | 21,994.00 |
| Jun 30, 2022 | 25,493.00 |
| Mar 31, 2022 | 30,299.00 |
| Dec 31, 2021 | 6,639.00 |
| Sep 30, 2021 | 8,084.00 |